Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Memory T cells in the skin balance staying put and moving into the blood, clustering around hair follicles, and increasing in number after infection.

Both induced and spontaneous AA lymphocytes can cause alopecia areata in mice.

Severe alopecia areata involves higher levels of certain immune cells, which can be normalized with betamethasone.

Melanocyte-associated antigens may play a key role in alopecia areata and could be targets for new treatments.

The study developed a mouse model for Alopecia Areata that responds to treatment, useful for future research.

Tacrolimus effectively promotes hair regrowth in an alopecia areata mouse model.

CD3+ T-cell presence is a reliable marker to tell apart alopecia areata from pattern hair loss.

The patient had a severe allergic reaction to gold treatment.

Melanocytes might be targeted by the immune system in people with alopecia areata, but more research is needed.

Targeting the AhR pathway may help treat alopecia areata.

Alopecia areata can be an early sign of Hodgkin’s lymphoma and may improve with lymphoma treatment.

Alopecia areata involves specific T-cells, unlike androgenetic alopecia.

A man got six skin cancers within a year after a cell transplant for leukemia but was cancer-free 32 months later; skin checks are important post-transplant.

AI can help diagnose Follicular Lymphoma by accurately identifying specific cell types.

Epidermal resident memory T cells play a crucial role in skin immunity and disease understanding.

PCFCL may have unrecognized subtypes and needs more research.

Alopecia areata patients show increased inflammation and OX40 activation, suggesting a new treatment target.

Gamma/delta T cells help defend skin against heavy metals.

Increased Toll-like receptors in blood cells may contribute to alopecia areata and could be a target for new treatments.

Areata-like lupus can mimic alopecia areata but is a form of cutaneous lupus erythematosus.

Alopecia areata involves persistent gene abnormalities and immune activity, even in regrown hair, suggesting a risk of relapse.

A patient's skin rash did not affect the area where a previous viral rash was healing, suggesting a rare immune response.

Acne patients' skin, both with and without lesions, shows a strong immune response and higher antimicrobial activity.

Type-2 immunity may influence skin diseases and could be targeted for treatment.

Machine learning can predict how well patients with alopecia areata will respond to certain treatments.

A humanized IL-2 fusion protein boosts T regulatory cells and helps control hair loss in Alopecia Areata.

Targeting specific T cells may help treat alopecia areata.

Keratin 14 may be an autoantigen in autoimmune skin diseases.

Blocking CD44 can reduce leukocyte migration in autoimmune skin diseases.